Shlomo Yanai Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shlomo Yanai.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shlomo Yanai. Shlomo Yanai is Director in CAMBREX CORP ($CBM) and Director in PDL BIOPHARMA, INC. ($PDLI) and Director in W R GRACE & CO ($GRA) and in Sagent Pharmaceuticals, Inc. ($SGNT) and Director in Sagent Pharmaceuticals, Inc. ($SGNT) and Director in Philip Morris International Inc. ($PM) and Director in PERRIGO Co plc ($PRGO) and Director in Exela Technologies, Inc. ($QPAC) and Director in Amneal Pharmaceuticals, Inc. ($AMRX).
Latest Insider Trading Transactions of Shlomo Yanai
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRX, CBM, QPAC, PDLI, PRGO, PM, SGNT, GRA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2021 | GRA | W R GRACE & CO | Yanai Shlomo | Director | Grant | A | 0.00 | 1,683 | 0 | 6,973 | 5.3 K to 7 K (+31.81 %) |
May 07 2021 | PM | Philip Morris Inte ... | Yanai Shlomo | Director | Grant | A | 95.18 | 1,839 | 175,027 | 1,839 | 0 to 1.8 K |
May 07 2021 | PM | Philip Morris Inte ... | Yanai Shlomo | Director | Grant | A | 95.18 | 1,839 | 175,027 | 1,839 | 0 to 1.8 K |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | M | 0.00 | 46,218 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 35,406 | 0 | 35,406 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Buy | M | 0.00 | 46,218 | 0 | 53,740 | 7.5 K to 53.7 K (+614.44 %) |
Dec 18 2020 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | M | 0.00 | 7,522 | 0 | 0 | |
Dec 18 2020 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Buy | M | 0.00 | 7,522 | 0 | 7,522 | 0 to 7.5 K |
May 14 2020 | GRA | W R GRACE & CO | Yanai Shlomo | Director | Grant | A | 0.00 | 2,280 | 0 | 5,290 | 3 K to 5.3 K (+75.75 %) |
May 06 2020 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 46,218 | 0 | 46,218 | |
Dec 17 2019 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 7,522 | 0 | 7,522 | |
Dec 17 2019 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 4.76 | 28,506 | 135,689 | 28,506 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 40.06 | 2,766 | 110,806 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 53.70 | 1,980 | 106,326 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 58.98 | 1,577 | 93,011 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 45.12 | 1,613 | 72,779 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 41.23 | 2,140 | 88,222 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 21.70 | 3,863 | 83,827 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 12.90 | 6,371 | 82,186 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Sell | S | 60.00 | 35,796 | 2,147,760 | 0 | 35.8 K to 0 (-100.00 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 40.06 | 2,766 | 110,806 | 35,796 | 33 K to 35.8 K (+8.37 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 53.70 | 1,980 | 106,326 | 33,030 | 31.1 K to 33 K (+6.38 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 58.98 | 1,577 | 93,011 | 31,050 | 29.5 K to 31.1 K (+5.35 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 45.12 | 1,613 | 72,779 | 29,473 | 27.9 K to 29.5 K (+5.79 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 41.23 | 2,140 | 88,222 | 27,860 | 25.7 K to 27.9 K (+8.32 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 40.06 | 2,766 | 110,806 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 21.70 | 3,863 | 83,827 | 25,720 | 21.9 K to 25.7 K (+17.67 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 53.70 | 1,980 | 106,326 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 12.90 | 6,371 | 82,186 | 21,857 | 15.5 K to 21.9 K (+41.14 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 58.98 | 1,577 | 93,011 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 45.12 | 1,613 | 72,779 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 41.23 | 2,140 | 88,222 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 21.70 | 3,863 | 83,827 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 12.90 | 6,371 | 82,186 | 0 | |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Sell | S | 60.00 | 35,796 | 2,147,760 | 0 | 35.8 K to 0 (-100.00 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 40.06 | 2,766 | 110,806 | 35,796 | 33 K to 35.8 K (+8.37 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 53.70 | 1,980 | 106,326 | 33,030 | 31.1 K to 33 K (+6.38 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 58.98 | 1,577 | 93,011 | 31,050 | 29.5 K to 31.1 K (+5.35 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 45.12 | 1,613 | 72,779 | 29,473 | 27.9 K to 29.5 K (+5.79 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 41.23 | 2,140 | 88,222 | 27,860 | 25.7 K to 27.9 K (+8.32 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 21.70 | 3,863 | 83,827 | 25,720 | 21.9 K to 25.7 K (+17.67 %) |
Dec 05 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Buy | M | 12.90 | 6,371 | 82,186 | 21,857 | 15.5 K to 21.9 K (+41.14 %) |
Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | Yanai Shlomo | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | Yanai Shlomo | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
May 09 2019 | GRA | W R GRACE & CO | Yanai Shlomo | Director | Grant | A | 0.00 | 1,532 | 0 | 3,010 | 1.5 K to 3 K (+103.65 %) |
Apr 25 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | A | 40.06 | 2,766 | 110,806 | 2,766 | |
Apr 25 2019 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Grant | A | 0.00 | 2,247 | 0 | 15,486 | 13.2 K to 15.5 K (+16.97 %) |
Jun 12 2018 | PDLI | PDL BIOPHARMA, INC ... | Yanai Shlomo | Director | Grant | A | 2.76 | 54,348 | 150,000 | 54,348 | 0 to 54.3 K |
May 11 2018 | GRA | W R GRACE & CO | Yanai Shlomo | Director | Grant | A | 0.00 | 1,478 | 0 | 1,478 | 0 to 1.5 K |
Apr 30 2018 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | A | 53.70 | 1,980 | 106,326 | 1,980 | |
Apr 30 2018 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | A | 53.70 | 1,980 | 106,326 | 1,980 | |
Apr 30 2018 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Grant | A | 0.00 | 1,397 | 0 | 13,239 | 11.8 K to 13.2 K (+11.80 %) |
Apr 30 2018 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Grant | A | 0.00 | 1,397 | 0 | 13,239 | 11.8 K to 13.2 K (+11.80 %) |
Jul 14 2017 | QPAC | Exela Technologies ... | Yanai Shlomo | Director | Sell | D | 0.00 | 29,500 | 0 | 20,500 | 50 K to 20.5 K (-59.00 %) |
May 01 2017 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | A | 58.98 | 1,577 | 93,011 | 1,577 | |
May 01 2017 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Grant | A | 0.00 | 1,187 | 0 | 11,842 | 10.7 K to 11.8 K (+11.14 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | D | 0.00 | 2,228 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Sell | D | 21.75 | 742 | 16,139 | 0 | 742 to 0 (-100.00 %) |
May 23 2016 | PRGO | PERRIGO Co plc | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 3,263 | 0 | 3,263 | |
Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Option Exercise | A | 0.00 | 8,556 | 0 | 8,556 | ||
Apr 22 2016 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | A | 45.12 | 1,613 | 72,779 | 1,613 | |
Apr 22 2016 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Grant | A | 0.00 | 1,330 | 0 | 10,655 | 9.3 K to 10.7 K (+14.26 %) |
Apr 18 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Option Exercise | M | 0.00 | 742 | 0 | 2,228 | ||
Apr 18 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Buy | M | 0.00 | 742 | 0 | 742 | 0 to 742 | |
Nov 06 2015 | PRGO | PERRIGO Co plc | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 924 | 0 | 924 | |
May 01 2015 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | A | 41.23 | 2,140 | 88,222 | 2,140 | |
May 01 2015 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Grant | A | 0.00 | 1,271 | 0 | 9,325 | 8.1 K to 9.3 K (+15.78 %) |
Apr 17 2015 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 2,970 | 0 | 2,970 | |
Apr 28 2014 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 21.70 | 3,863 | 83,827 | 3,863 | |
Apr 28 2014 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Grant | A | 0.00 | 2,403 | 0 | 8,054 | 5.7 K to 8.1 K (+42.52 %) |
Apr 29 2013 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Option Exercise | M | 12.90 | 6,371 | 82,186 | 6,371 | |
Apr 29 2013 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Grant | A | 0.00 | 3,956 | 0 | 5,651 | 1.7 K to 5.7 K (+233.39 %) |
Nov 29 2012 | CBM | CAMBREX CORP | Yanai Shlomo | Director | Grant | A | 0.00 | 1,695 | 0 | 1,695 | 0 to 1.7 K |
Page: 1